Skip to main content

Phatabulous Fashion

 

























































Comments

Post a Comment

Popular posts from this blog

Plus Size Influencer Regrets Body Positivity Movement

Phases, Freedom & the Evolution of Body Positivity For over a decade, Gabriella Lascano built a platform rooted in self-love. In 2010, long before brand deals and viral TikToks, Lascano began posting on YouTube. She has shared that from a young age, “I always knew I was bigger.” She dreamed of being a star but believed her size would disqualify her. Online, however, she found something different: a community of plus-size women who felt empowered seeing someone who looked like them living boldly. “That just made me feel like I had a bigger purpose in what I was creating,” she said in a recent opinion video. With more than 600,000 followers across platforms, Lascano became part of a digital wave that helped redefine beauty standards. She spoke about confidence, fashion, and taking up space without apology. For many women, the body positivity movement felt like paradise — no pressure to shrink, no demand to conform. But over time, her perspective shifted. Three years ago, Lascano post...
Post a Comment
Read more

Ozempic Culture is Here, But What Happens to Body Positivity?

When Thin Became Trendy Again: Who Gets Left Behind? By Phatabulous Magazine Staff Ozempic Culture & the Quiet Rollback of Body Positivity For a brief, shimmering moment, it felt like the world was finally catching up. Plus-size women were visible. Fashion brands expanded their sizing. Campaigns spoke the language of “body neutrality,” “health at every size,” and “confidence without apology.” Fat bodies weren’t just tolerated—they were styled, centered, and celebrated. And then, almost overnight, thin became trendy again. Not because the science changed. Not because fat bodies suddenly became unhealthy. But because Ozempic culture arrived. Watch Commentary Video GLP-1 weight-loss drugs like Ozempic, Wegovy, and Zepbound have reshaped beauty standards at record speed. What began as a medical intervention for diabetes and obesity has quietly morphed into a cultural reset—one where shrinking is praised, staying the same is questioned, and opting out feels like rebellion. Plus-size mod...
Post a Comment
Read more

Willpower or Wellness? Mo’Nique’s Warning on GLP-1 Weight Loss Drugs

Willpower or Wellness? Mo’Nique’s Warning on GLP-1 Weight Loss Drugs By Phatabulous Magazine When Mo’Nique speaks, she doesn’t whisper. She testifies. The Oscar-winning actress and comedian recently shared her concerns about the growing popularity of GLP-1 weight-loss drugs, questioning whether we are sacrificing something deeper than pounds on the scale. “What is the long-term effects? What will it do to your body? Your mind? What will it do to us five years from now, 10 years from now?” she asked in a heartfelt video. “They’re taking away our willpower. They’re taking away our fight.” Her message wasn’t just about medication. It was about autonomy. About discipline. About self-trust. And for many in the plus-size community, her words landed heavy. GLP-1 medications like Ozempic, Wegovy, and Mounjaro were originally developed to treat type 2 diabetes. They mimic a hormone that regulates blood sugar and appetite, helping people feel full faster and longer. In recent years, they’ve beco...
Post a Comment
Read more